InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | Cormorant Asset Management, LP | Former 10% Owner | Sale | 109.3K | $89.50 | $9.79M | 950.0K | View ↗ |
No financial data available for DRUG.
Company may not file with SEC or CIK is unresolved.
Shroom stocks rise as Trump is said to sign executive order on psychedelic drug
What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate?
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
Bright Minds Biosciences to Present at Upcoming Conferences